SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
355Artemis and Taconic Acquire Chemical Genetics Technology From CGI Pharmaceuticalscaram(o)uche-5/2/2007
354<In less than four months, we have filed three INDs> and <This is the 1kenhott-4/26/2007
353Exelixis Files IND Application for XL765 Apr 25, 2007 06:00:00 (ET) SOUTH SANLJM-4/25/2007
352We know cancers are hard to kill. At least two ways to look at it. (1) We are skenhott-4/9/2007
351Interesting discussion of kinase inhibitors in general, and c-MET inhibitors, intuck-4/9/2007
350Exelixis Files IND Application for XL147 Friday March 16, 6:00 am ET -Companynigel bates-3/16/2007
349GS: Exelixis, Inc. (EXEL): Pipeline continues to advance. Phase 2 trials to resumopgcw-3/8/2007
348>>Exelixis Announces Fourth Quarter 2006 and Full Year 2006 Financial Resutuck-2/13/2007
347Probably the CFO. Bet he lies awake at night sometimes.nigel bates-1/30/2007
346What one can not gather one can not see. Time for my meditation. :)kenhott-1/30/2007
345They are approaching the Medarex clinical trial saturation level now. One more IIcebrg-1/30/2007
344Exelixis Files IND Application for XL418 Tuesday January 30, 6:00 am ET SOUTH Snigel bates-1/30/2007
343Item 8.01 Other Events. On January 19, 2007, Exelixis, Inc. (the “Company”) reIcebrg-1/26/2007
342On January 4, 2007, Exelixis, Inc. (the “Company”) announced that it had appointkeokalani'nui-1/5/2007
341Jeff Latts Exel EVP. Drug Dev retires. "I'm fuggin' worn out."keokalani'nui-1/4/2007
340Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncoloscaram(o)uche-1/3/2007
339$40m is the going rate for IND-ready cpd. Getting easy to do valuation!keokalani'nui-12/31/2006
338pcop too, about two minutes ago.... Wyeth.scaram(o)uche-12/29/2006
337guffaw! uh...... yeah, it was probably heads or tails, even for the 8-K. :-scaram(o)uche-12/29/2006
336Probably. And who knows so many deals and molecules, the 20th in line is gettingrkrw-12/29/2006
335line those molecules up and shoot them down the preclinical pipe...... :-)scaram(o)uche-12/29/2006
334looks like there was a milestone that was already in hand by the time the deal wscaram(o)uche-12/29/2006
333Strange exel never put out a PR on the deal. Good find. rkrw-12/29/2006
33229-Dec-2006 Entry into a Material Definitive Agreement Item 1.01. Entry into ascaram(o)uche-12/29/2006
3318K out, Genentech collaboration, 12/22.scaram(o)uche-12/29/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News